These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 35179454)

  • 41. The experiences of people who inject drugs of skin and soft tissue infections and harm reduction: A qualitative study.
    Dunleavy K; Hope V; Roy K; Taylor A
    Int J Drug Policy; 2019 Mar; 65():65-72. PubMed ID: 30665085
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Differences by sex in associations between injection drug risks and drug crime conviction among people who inject drugs in Almaty, Kazakhstan.
    Marotta PL; Gilbert L; Terlikbayeva A; Wu E; El-Bassel N
    Int J Drug Policy; 2018 Oct; 60():96-106. PubMed ID: 30219718
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Polydrug Use and Heterogeneity in HIV Risk Among People Who Inject Drugs in Estonia and Russia: A Latent Class Analysis.
    Tavitian-Exley I; Boily MC; Heimer R; Uusküla A; Levina O; Maheu-Giroux M
    AIDS Behav; 2018 Apr; 22(4):1329-1340. PubMed ID: 28699018
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Injection risk norms and practices among migrant Puerto Rican people who inject drugs in New York City: The limits of acculturation theory.
    Gelpí-Acosta C; Guarino H; Benoit E; Deren S; Pouget ER; Rodríguez A
    Int J Drug Policy; 2019 Jul; 69():60-69. PubMed ID: 31196730
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Potential geographic "hotspots" for drug-injection related transmission of HIV and HCV and for initiation into injecting drug use in New York City, 2011-2015, with implications for the current opioid epidemic in the US.
    Des Jarlais DC; Cooper HLF; Arasteh K; Feelemyer J; McKnight C; Ross Z
    PLoS One; 2018; 13(3):e0194799. PubMed ID: 29596464
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Randomized controlled trial of motivational interviewing for reducing injection risk behaviours among people who inject drugs.
    Bertrand K; Roy É; Vaillancourt É; Vandermeerschen J; Berbiche D; Boivin JF
    Addiction; 2015 May; 110(5):832-41. PubMed ID: 25641704
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Design and baseline findings of a large-scale rapid response to an HIV outbreak in people who inject drugs in Athens, Greece: the ARISTOTLE programme.
    Hatzakis A; Sypsa V; Paraskevis D; Nikolopoulos G; Tsiara C; Micha K; Panopoulos A; Malliori M; Psichogiou M; Pharris A; Wiessing L; van de Laar M; Donoghoe M; Heckathorn DD; Friedman SR; Des Jarlais DC
    Addiction; 2015 Sep; 110(9):1453-67. PubMed ID: 26032121
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prevalence of HIV and other infections and injection behaviours among people who inject drugs in Addis Ababa, Ethiopia.
    Demissie M; Johnston LG; Muleta M; Desyebelew D; Belete W; G/Egxiabehre A; Gezahegn N; Kassa D; Aseffa Y
    Afr J AIDS Res; 2018 Sep; 17(3):259-264. PubMed ID: 30319040
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Willingness to use HIV pre-exposure prophylaxis among community-recruited, older people who inject drugs in Washington, DC.
    Kuo I; Olsen H; Patrick R; Phillips G; Magnus M; Opoku J; Rawls A; Peterson J; Hamilton F; Kharfen M; Greenberg A
    Drug Alcohol Depend; 2016 Jul; 164():8-13. PubMed ID: 27177804
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Association of depression, anxiety, and suicidal ideation with high-risk behaviors among men who inject drugs in Delhi, India.
    Armstrong G; Jorm AF; Samson L; Joubert L; Nuken A; Singh S; Kermode M
    J Acquir Immune Defic Syndr; 2013 Dec; 64(5):502-10. PubMed ID: 23933769
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Factors that influence the characteristics of needles and syringes used by people who inject drugs in Tajikistan.
    Zule WA; Latypov A; Otiashvili D; Kirtadze I; Ibragimov U; Bobashev GV
    Harm Reduct J; 2015 Oct; 12():37. PubMed ID: 26472669
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Latent classes of polydrug and polyroute use and associations with human immunodeficiency virus risk behaviours and overdose among people who inject drugs in Tijuana, Baja California, Mexico.
    Meacham MC; Roesch SC; Strathdee SA; Lindsay S; Gonzalez-Zuniga P; Gaines TL
    Drug Alcohol Rev; 2018 Jan; 37(1):128-136. PubMed ID: 28337798
    [TBL] [Abstract][Full Text] [Related]  

  • 53. HIV care continuum among men who have sex with men and persons who inject drugs in India: barriers to successful engagement.
    Mehta SH; Lucas GM; Solomon S; Srikrishnan AK; McFall AM; Dhingra N; Nandagopal P; Kumar MS; Celentano DD; Solomon SS
    Clin Infect Dis; 2015 Dec; 61(11):1732-41. PubMed ID: 26251048
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Age-Related Differences in Past or Present Hepatitis C Virus Infection Among People Who Inject Drugs: National Human Immunodeficiency Virus Behavioral Surveillance, 8 US Cities, 2015.
    Abara WE; Trujillo L; Broz D; Finlayson T; Teshale E; Paz-Bailey G; Glick S; Al-Tayyib AA; Robinson WT; Masiello-Schuette S; Sey EK; Anderson BJ; Poe J; Braunstein S
    J Infect Dis; 2019 Jul; 220(3):377-385. PubMed ID: 30915477
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Gender-specific associations between psychological distress and injecting risk behaviours among people who inject drugs in Montreal, Canada.
    Minoyan N; Høj SB; Jutras-Aswad D; Vlad D; Martel-Laferrière V; Sylvestre MP; Bruneau J
    Int J Drug Policy; 2021 Oct; 96():103319. PubMed ID: 34154905
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Association of sociodemographic factors with needle sharing and number of sex partners among people who inject drugs in Egypt.
    Anwar S; El Kharrat E; Bakhoum A; El-Sadr WM; Harris TG
    Glob Public Health; 2022 Aug; 17(8):1689-1698. PubMed ID: 34283695
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Understanding differences in HIV/HCV prevalence according to differentiated risk behaviors in a sample of PWID in rural Puerto Rico.
    Abadie R; Welch-Lazoritz M; Gelpi-Acosta C; Reyes JC; Dombrowski K
    Harm Reduct J; 2016 Mar; 13():10. PubMed ID: 26956029
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Uptake of needle and syringe program services in the Kyrgyz Republic: Key barriers and facilitators.
    Deryabina A; El-Sadr WM
    Drug Alcohol Depend; 2017 Oct; 179():180-186. PubMed ID: 28787695
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Drug use stigma and its association with active hepatitis C virus infection and injection drug use behaviors among community-based people who inject drugs in India.
    Patel EU; Solomon SS; Lucas GM; McFall AM; Tomori C; Srikrishnan AK; Kumar MS; Laeyendecker O; Celentano DD; Thomas DL; Quinn TC; Mehta SH
    Int J Drug Policy; 2021 Oct; 96():103354. PubMed ID: 34247900
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prevalence of hepatitis C and pre-testing awareness of hepatitis C status in 1500 consecutive PWID participants at the Stockholm needle exchange program.
    Kåberg M; Hammarberg A; Lidman C; Weiland O
    Infect Dis (Lond); 2017 Oct; 49(10):728-736. PubMed ID: 28574295
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.